-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
KESTRA MEDICAL TECHNOLOGIES, LTD. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 30 Apr 2024 to 31 Jul 2025.
- KESTRA MEDICAL TECHNOLOGIES, LTD. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Jul 2025 was $1,875,000, a 102% decline year-over-year.
- KESTRA MEDICAL TECHNOLOGIES, LTD. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $330,262,000, a 325% increase from 2023.